Aβ seeds resist inactivation by formaldehyde

Acta Neuropathologica

Volumn 128, Issue 4, 2014, Pages 477-484

  Fritschi, Sarah K ^a,b,c   Cintron, Amarallys ^d   Ye, Lan ^a,b,c   Mahler, Jasmin ^a,b,c   Bühler, Anika ^a,b   Baumann, Frank ^a,b   Neumann, Manuela ^a,c   Nilsson, K Peter R ^f   Hammarström, Per ^f   Walker, Lary C ^d,e   Jucker, Mathias ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d EMORY UNIVERSITY   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Alzheimer; Amyloid; Fixation; Prion; Strain

Indexed keywords

AMYLOID BETA PROTEIN; DYE; FORMALDEHYDE; AMYLOID BETA PROTEIN[1-40]; AMYLOID PRECURSOR PROTEIN; FIXATIVE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN TISSUE; CHEMICAL STRUCTURE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; MALE; MOUSE; NONHUMAN; PROTEIN AGGREGATION; SPECTROSCOPY; TRANSGENIC MOUSE; AGE; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AUTOPSY; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; PEPTIDE FRAGMENTS;

EID: 84919882433     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1339-2     Document Type: Article

References (35)

1. Bondolfi L, Calhoun M, Ermini F, Kuhn HG, Wiederhold K-H, Walker L, Staufenbiel M, Jucker M (2002) Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice. J Neurosci 22:515–522
2. Brown F (2001) Inactivation of viruses by aziridines. Vaccine 20:322–327
3. Brown P, Brandel J-P, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerging Infect Dis 18:901–907. doi:10.3201/eid1806.120116
4. Brown P, Gibbs CJ, Gajdusek DC, Cathala F, LaBauge R (1986) Transmission of Creutzfeldt-Jakob disease from formalin-fixed, paraffin-embedded human brain tissue. N Engl J Med 315:1614–1615. doi:10.1056/NEJM198612183152516
5. Brown P, Liberski PP, Wolff A, Gajdusek DC (1990) Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 161:467–472
6. Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887–890
7. Delrue I, Verzele D, Madder A, Nauwynck HJ (2012) Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges. Expert Rev Vaccines 11:695–719. doi:10.1586/erv.12.38
8. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan Z-X, Roth K, Aguzzi A, Staufenbiel M, Walker LC, Jucker M (2009) Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci 106:12926–12931. doi:10.1073/pnas.0903200106
9. Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, Walker LC, Staufenbiel M, Heikenwalder M, Jucker M (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:980–982. doi:10.1126/science.1194516
10. Gordon WS (1946) Advances in veterinary research. Vet Rec 58:516–525
11. Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M (2012) The presence of Aβ seeds, and not age per se, is critical to the initiation of Aβ deposition in the brain. Acta Neuropathol 123:31–37. doi:10.1007/s00401-011-0912-1
12. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356. doi:10.1126/science.1072994
13. Heilbronner G, Eisele YS, Langer F, Kaeser SA, Novotny R, Nagarathinam A, Aslund A, Hammarström P, Nilsson KPR, Jucker M (2013) Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice. EMBO Rep 14:1017–1022. doi:10.1038/embor.2013.137
14. Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020. Cold Spring Harb Perspect Med. doi:10.1101/cshperspect.a011585
15. Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM-Y, Trojanowski JQ (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462. doi:10.1001/jamaneurol.2013.1933
16. Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45–51. doi:10.1038/nature12481
17. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC (2000) Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 20:3606–3611
18. Klingstedt T, Aslund A, Simon RA, Johansson LBG, Mason JJ, Nyström S, Hammarström P, Nilsson KPR (2011) Synthesis of a library of oligothiophenes and their utilization as fluorescent ligands for spectral assignment of protein aggregates. Org Biomol Chem 9:8356–8370. doi:10.1039/c1ob05637a
19. Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M (2011) Soluble A{beta} seeds Are potent inducers of cerebral {beta}-amyloid deposition. J Neurosci 31:14488–14495. doi:10.1523/JNEUROSCI.3088-11.2011
20. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret J-M, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313:1781–1784. doi:10.1126/science.1131864
21. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C (2011) De novo induction of amyloid-β deposition in vivo. Mol Psychiatry 17:1347–1353. doi:10.1038/mp.2011.120
22. Nagarathinam A, Höflinger P, Bühler A, Schäfer C, McGovern G, Jeffrey M, Staufenbiel M, Jucker M, Baumann F (2013) Membrane-anchored aβ accelerates amyloid formation and exacerbates amyloid-associated toxicity in mice. J Neurosci 33:19284–19294. doi:10.1523/JNEUROSCI.2542-13.2013
23. Pattison IH (1965) Resistance of the scrapie agent to formalin. J Comp Pathol 75:159–164
24. Pattison IH (1972) Scrapie—a personal view. J Clin Pathol Suppl (R Coll Pathol) 6:110–114
25. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363–13383
26. Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601–623. doi:10.1146/annurev-genet-110711-155524
27. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jäggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, Hölscher C, Mathews PM, Jucker M (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7:940–946. doi:10.1038/sj.embor.7400784
28. Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ, Levine H, Jucker M, Walker LC (2012) Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem 120:660–666. doi:10.1111/j.1471-4159.2011.07551.x
29. Rutala WA, Weber DJ, Society for Healthcare Epidemiology of America (2010) Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol 31:107–117. doi:10.1086/650197
30. Stöhr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ, Prusiner SB, Giles K (2012) Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions. Proc Natl Acad Sci 109:11025–11030. doi:10.1073/pnas.1206555109
31. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Bürki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287–13292
32. Taylor DM, Brown JM, Fernie K, McConnell I (1997) The effect of formic acid on BSE and scrapie infectivity in fixed and unfixed brain-tissue. Vet Microbiol 58:167–174
33. Taylor DM, McConnell I (1988) Autoclaving does not decontaminate formol-fixed scrapie tissues. Lancet 1:1463–1464
34. Walker LC, Callahan MJ, Bian F, Durham RA, Roher AE, Lipinski WJ (2002) Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23:1241–1247
35. Watts JC, Giles K, Grillo SK, Lemus A, DeArmond SJ, Prusiner SB (2011) Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer’s disease. Proc Natl Acad Sci 108:2528–2533. doi:10.1073/pnas.1019034108